US Patent 7812178 Isoquinoline compound and pharmaceutical use thereof
Patent 7812178 was granted and assigned to Mitsubishi Tanabe Pharma on October, 2010 by the United States Patent and Trademark Office.
All edits
The present invention relates to an isoquinoline compound represented by the following formula (I), an optically active form thereof, a pharmaceutically acceptable salt thereof, a water adduct thereof, a hydrate thereof and a solvate thereof, as well as an agent for the prophylaxis and/or treatment of a disease caused by hyperreactivity of poly(ADP-ribose)polymerase, containing the compound, and a poly(ADP-ribose)polymerase inhibitor containing the compound. In addition, this compound is useful as an agent for the prophylaxis and/or treatment of cerebral infarction, particularly as an agent for the prophylaxis and/or treatment of acute cerebral infarction. Furthermore, this compound is useful as a prophylactic and/or therapeutic agent that improves neurological symptoms associated with cerebral infarction, particularly acute cerebral infarction.
US Patent 07812178 Isoquinoline compound and pharmaceutical use thereof US Patent 7812178 Isoquinoline compound and pharmaceutical use thereof
US Patent 07812178 Isoquinoline compound and pharmaceutical use thereof
Find more entities like US Patent 7812178 Isoquinoline compound and pharmaceutical use thereof
